Bicocca Open Archive

Logo unimib boa
PESCI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.583
AS - Asia 7.928
EU - Europa 6.636
SA - Sud America 1.255
AF - Africa 207
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 6
Totale 31.640
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.792
SG - Singapore 2.898
CN - Cina 1.658
IT - Italia 1.290
DE - Germania 1.052
VN - Vietnam 1.051
HK - Hong Kong 997
RU - Federazione Russa 984
BR - Brasile 968
SE - Svezia 804
CA - Canada 658
IE - Irlanda 622
GB - Regno Unito 368
UA - Ucraina 362
FR - Francia 360
IN - India 252
FI - Finlandia 222
ID - Indonesia 193
AT - Austria 165
BD - Bangladesh 148
AR - Argentina 101
TR - Turchia 100
IQ - Iraq 95
KR - Corea 89
PK - Pakistan 80
MX - Messico 72
NL - Olanda 71
ZA - Sudafrica 65
DK - Danimarca 62
JP - Giappone 62
ES - Italia 55
SA - Arabia Saudita 54
CO - Colombia 44
PL - Polonia 43
BE - Belgio 34
EC - Ecuador 34
UZ - Uzbekistan 33
CZ - Repubblica Ceca 32
PH - Filippine 31
VE - Venezuela 31
CL - Cile 29
MA - Marocco 28
AE - Emirati Arabi Uniti 26
KE - Kenya 24
TN - Tunisia 20
AU - Australia 19
PY - Paraguay 19
CH - Svizzera 17
MY - Malesia 17
JO - Giordania 14
PE - Perù 14
PT - Portogallo 14
TH - Thailandia 14
AL - Albania 13
EG - Egitto 12
JM - Giamaica 12
NP - Nepal 12
OM - Oman 12
CR - Costa Rica 11
IR - Iran 11
KZ - Kazakistan 11
RO - Romania 11
KG - Kirghizistan 10
LB - Libano 10
DZ - Algeria 9
ET - Etiopia 9
IL - Israele 9
DO - Repubblica Dominicana 8
PA - Panama 8
UY - Uruguay 8
HN - Honduras 7
LT - Lituania 7
PS - Palestinian Territory 7
BO - Bolivia 6
BY - Bielorussia 6
GR - Grecia 6
NZ - Nuova Zelanda 6
BH - Bahrain 5
EE - Estonia 5
HU - Ungheria 5
MD - Moldavia 5
NG - Nigeria 5
RS - Serbia 5
SC - Seychelles 5
AZ - Azerbaigian 4
BG - Bulgaria 4
KH - Cambogia 4
MN - Mongolia 4
MU - Mauritius 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BB - Barbados 3
CG - Congo 3
GA - Gabon 3
GE - Georgia 3
NI - Nicaragua 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
BW - Botswana 2
CY - Cipro 2
Totale 31.596
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.538
Singapore 1.733
Ashburn 1.245
Hong Kong 987
San Jose 946
Fairfield 907
Woodbridge 862
Chandler 851
Frankfurt am Main 671
Dublin 603
Houston 594
Wilmington 552
Toronto 495
New York 417
Dearborn 351
Jacksonville 345
Seattle 345
Ho Chi Minh City 293
Cambridge 291
Milan 261
Los Angeles 255
Princeton 240
Hanoi 237
Santa Clara 234
Beijing 227
Dallas 222
The Dalles 221
Chicago 215
Jakarta 154
Nanjing 145
Vienna 141
Shanghai 138
Council Bluffs 128
Lauterbourg 125
Buffalo 119
Hefei 119
Altamura 113
São Paulo 108
Lawrence 106
Helsinki 103
Moscow 103
Boardman 79
Seoul 79
Munich 72
Guangzhou 71
San Diego 61
Lachine 56
Dong Ket 52
Tokyo 50
Nanchang 49
Orem 47
London 46
Da Nang 44
Fremont 42
Nuremberg 39
Jinan 37
Lappeenranta 36
Baghdad 35
Haiphong 34
Shenyang 34
Andover 33
Columbus 33
Hebei 33
Atlanta 32
Brussels 32
Montreal 31
Rome 31
Tashkent 31
Phoenix 30
Dhaka 29
Salt Lake City 29
Warsaw 29
Amsterdam 28
Brooklyn 27
Tianjin 27
Jiaxing 26
Johannesburg 26
Lissone 26
Stockholm 26
Lahore 25
Hải Dương 24
Monza 23
Rio de Janeiro 23
Riyadh 23
Turku 23
Belo Horizonte 22
Denver 22
Mexico City 22
Porto Alegre 22
Brasília 21
Brno 21
Changsha 21
Chennai 21
Hangzhou 21
Mumbai 20
Nairobi 20
Norwalk 20
Düsseldorf 19
Manchester 19
Ankara 18
Totale 20.712
Salva come PNG Salva come JPEG
Nome #
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 501
Progressive fibrosing interstitial lung diseases: prevalence and characterization in two Italian referral centers 435
Noninvasive ventilation weaning in acute hypercapnic respiratory failure due to COPD exacerbation: A real-life observational study 425
Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights 418
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 409
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection 395
Delirium symptoms during hospitalization predict long-term mortality in patients with severe pneumonia 374
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 366
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study 356
Rehospitalization for pneumonia after first pneumonia admission: Incidence and predictors in a population-based cohort study 352
The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone 349
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 348
Prolonged exposure to welding fumes as a novel cause of systemic iron overload 340
Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential 336
Response to: Comment on "Noninvasive Ventilation Weaning in Acute Hypercapnic Respiratory Failure due to COPD Exacerbation: A Real-Life Observational Study" 332
Corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A single center experience and literature review 331
Clinical phenotypes in adult patients with bronchiectasis 326
Regional differences in bronchial reactivity assessed by respiratory impedance 324
Non-specific interstitial pneumonia and features of connective tissue disease: What are the consequences of a different point of view? 324
Interstitial pneumonia with autoimmune features: an additional risk factor for ARDS? 317
Management of acute respiratory failure in interstitial lung diseases: Overview and clinical insights 315
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 309
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 309
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases 307
Impact of traffic-related air pollution on pulmonary oxidative stress 303
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 303
Dyspnea in crackling lungs 301
Cardiovascular autonomic alterations in hospitalized patients with community-acquired pneumonia 300
A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis 300
Renal involvement in Churg-Strauss syndrome 299
Characterization of bronchiectasis in the elderly 296
Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study 296
C-arm cone-beam CT-guided transthoracic lung core needle biopsy as a standard diagnostic tool 293
An unusual presentation of pulmonary lymphoma: When diffuse ground glass opacities can mean anything 290
Multidimensional severity assessment in bronchiectasis: An analysis of seven European cohorts 288
Efficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life study 287
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 287
Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy 286
Economic impact of anti-IL-5 agents in patients with severe eosinophilic asthma: A population-based cohort study 285
A 61-year-old female with chronic cough and purulent sputum 284
Influenza A/H1N1 severe pneumonia: Novel morphocytological findings in bronchoalveolar lavage 280
Allergic bronchopulmonary aspergillosis screening in bronchiectasis: Is there always a precise answer to a clear question? 280
HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome 279
Macrolidi a lungo termine nella broncopneumopatia cronica ostruttiva 278
Can healthcare utilization data reliably capture cases of chronic respiratory diseases? A cross-sectional investigation in Italy 277
Progression of obstructive ventilatory disorder in Fabry disease: Only a matter of time? 276
Effectiveness and economic impact of Dupilumab in asthma: a population-based cohort study 274
Psychometric properties and minimal important differences of SF-36 in Idiopathic Pulmonary Fibrosis 274
Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study 274
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study 272
Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity 269
Differences between acute exacerbations of idiopathic pulmonary fibrosis and other interstitial lung diseases 266
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study 263
162. Cluster analysis to explore clinical subclassification of eosinophilic granulomatosis with polyangiitis (churg–strauss) 258
Il lavaggio broncoalveolare nelle pneumopatie infiltrative diffuse 255
Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist 255
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 254
Diaphragm ultrasonography in the management of patients with amyotrophic lateral sclerosis 248
Persistence with inhaled corticosteroids reduces the risk of exacerbation among adults with asthma: A real-world investigation 248
Geriatric multidimensional assessment for elderly patients with acute respiratory diseases 247
Pirfenidone in real life: A retrospective observational multicentre study in Italian patients with idiopathic pulmonary fibrosis 247
History of lung volume reduction procedures 245
Metallic elements in exhaled breath condensate of patients with interstitial lung diseases 244
Short-term Evolution of Nutritional Status in Patients with Idiopathic Pulmonary Fibrosis 243
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 243
Alpha glucocorticoid receptor expression in different experimental rat models of acute lung injury 242
The management of community-acquired pneumonia in the elderly 242
Molecular biomarkers in idiopathic pulmonary fibrosis: State of the art and future directions 242
Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis 239
Clinical course of IPF in Italian patients during 12 months of observation: results from the FIBRONET observational study 239
Non-tuberculous Mycobacterial Pulmonary Disease: an Italian National Survey 238
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19 236
Feasibility of CPAP application and variables related to worsening of respiratory failure in pregnant women with SARS-CoV-2 pneumonia: Experience of a tertiary care centre 235
Bronchoalveolar lavage in idiopathic pulmonary fibrosis: What does it tell us? 234
COPD: maximization of bronchodilation 230
EBUS-TBNA nella patologia mediastino-polmonare: analisi retrospettiva dei primi 3 anni di attività di un singolo centro 229
Impact of N-acetyl-L-cysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study 229
Uterine carcinosarcoma metastatic to the lung as large-cell neuroendocrine carcinoma with synchronous sarcoid granulomatosis 227
Interstitial lung diseases in a lung cancer screening trial 225
A case of ARDS associated with influenza A - H1N1 infection treated with extracorporeal respiratory support 224
Systemic sclerosis and outcome in intensive care unit: Do not close the door, open the right protocol 219
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 218
Feasibility and clinical impact of a portable bi-level ventilation device in patients with severe chronic obstructive pulmonary disease and exertional dyspnea: preliminary results from a clinical series 217
Covid-19 and the role of smoking: The protocol of the multicentric prospective study COSMO-IT (covid19 and smoking in italy) 216
Cardiovascular Structural and Functional Parameters in Idiopathic Pulmonary Fibrosis at Disease Diagnosis 215
Acute myocardial infarction versus other cardiovascular events in communityacquired pneumonia 214
The bronchiectasis severity index. An international derivation and validation study 212
Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approach 210
Early recognition of airway obstruction in Fabry disease and correlation with dyspnea: A case series 208
Right ventricular reverse remodelling in Idiopathic Pulmonary Arterial Hypertension diagnosed during pregnancy: Is it possible? 207
Fcγ-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitis 204
Optimization of ventilator setting by flow and pressure waveforms analysis during noninvasive ventilation for acute exacerbations of COPD: a multicentric randomized controlled trial 200
Alveolar Diseases 199
Respiratory system involvement in ANCA-associated systemic vasculitides 198
Circadian rhythm of COPD symptoms in clinically based phenotypes. Results from the STORICO Italian observational study 198
Respiratory viruses in stable bronchiectasis: A multicenter evaluation in Northern Italy 196
Surgical and endoscopic treatment for COPD: Patients selection, techniques and results 196
Long-term macrolides in diffuse interstitial lung diseases 192
Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis 191
Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia 191
Totale 27.457
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.246
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.246
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021245 0 0 0 0 0 0 0 0 0 0 0 245
2021/20221.968 194 206 232 210 109 161 65 95 75 140 156 325
2022/20233.101 347 865 350 289 186 471 36 179 215 22 82 59
2023/20241.995 52 61 107 97 247 551 367 90 122 33 32 236
2024/20254.818 282 524 250 205 411 247 258 226 520 827 399 669
2025/202611.225 1.358 611 819 1.159 1.308 675 1.733 550 1.045 967 723 277
Totale 32.335